Drugs / pSil-miR200c
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02579187 Comparator | Dec 2025 → Sep 2030 | — | Gustavo Avila-Ortiz DDS, MS, PhD | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pSil-miR200c | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02579187 ↗ |
| Modality | Other / unclassified | “pSil-miR200c plasmids” NCT02579187 ↗ |
| Route | Other | “10µg of pSil-miR200c plasmids in a biodegradable sponge” NCT02579187 ↗ |